Amneal Pharmaceuticals, Inc.
AMRX
Revenue
730.52M
▲28.05M▲3.99%
3 Months ChangeAssets
3.50B
▲40.47M▲1.17%
3 Months ChangeLiabilities
0.00
0.000.00%
3 Months ChangeFree Cash Flow
-13.61M
▼-143.63M▼-110.47%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-01
Form 8-K
ID: 0001628280-24-041646
2024-08-09
Form 10-Q
ID: 0001723128-24-000032
2024-08-09
Form 8-K
ID: 0001723128-24-000030
2024-05-08
Form 10-Q
ID: 0001723128-24-000021
2024-05-07
Form 8-K
ID: 0001628280-24-021107
2024-05-03
Form 8-K
ID: 0001723128-24-000018
2024-03-01
Form 8-K
ID: 0001723128-24-000007
2024-01-10
Form 8-K
ID: 0001723128-24-000003
2023-12-15
Form 8-K
ID: 0001193125-23-296658
2023-11-14
Form 8-K
ID: 0001193125-23-277184